Literature DB >> 24931819

Myxedema.

Yue Cao1, Hui Juan Zhu2, He Yi Zheng3, Jun Li4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24931819     DOI： 10.1016/S2213-8587(14)70063-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  2 in total

1.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

2.  Bilateral breast myxedema caused by Graves' disease and responsive to multipoint subcutaneous injection of long-acting glucocorticoid: Case report.

Authors:  Tingting Du; Wangyan Jiang; Hongchang Luo; Fuqiong Chen; Gang Yuan; Muxun Zhang; Zhelong Liu
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.